WO2006091870A2 - Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis - Google Patents
Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis Download PDFInfo
- Publication number
- WO2006091870A2 WO2006091870A2 PCT/US2006/006698 US2006006698W WO2006091870A2 WO 2006091870 A2 WO2006091870 A2 WO 2006091870A2 US 2006006698 W US2006006698 W US 2006006698W WO 2006091870 A2 WO2006091870 A2 WO 2006091870A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- methyl
- substituted
- salt
- ethanol
- Prior art date
Links
- 0 *N1CCCCCCC1 Chemical compound *N1CCCCCCC1 0.000 description 6
- KUTAVMCJCVADGZ-BQYQJAHWSA-N COc1cc(OC)c(/C=C/S(Cc(cc2N)ccc2OC)(=O)=O)c(OC)c1 Chemical compound COc1cc(OC)c(/C=C/S(Cc(cc2N)ccc2OC)(=O)=O)c(OC)c1 KUTAVMCJCVADGZ-BQYQJAHWSA-N 0.000 description 1
- BQKFZDGYQKVTSI-UHFFFAOYSA-N COc1cc(OC)c(C(CS(Cc(cc2)cc([N+]([O-])=O)c2OC)(=O)=O)=O)c(OC)c1 Chemical compound COc1cc(OC)c(C(CS(Cc(cc2)cc([N+]([O-])=O)c2OC)(=O)=O)=O)c(OC)c1 BQKFZDGYQKVTSI-UHFFFAOYSA-N 0.000 description 1
- ZBGRUCCJKBMGRR-UHFFFAOYSA-N COc1cc(OC)c(C(CSCc(cc2)cc([N+]([O-])=O)c2OC)=O)c(OC)c1 Chemical compound COc1cc(OC)c(C(CSCc(cc2)cc([N+]([O-])=O)c2OC)=O)c(OC)c1 ZBGRUCCJKBMGRR-UHFFFAOYSA-N 0.000 description 1
- XVRLCBPJGSBPDS-UHFFFAOYSA-N COc1ccc(CS)cc1[N+]([O-])=O Chemical compound COc1ccc(CS)cc1[N+]([O-])=O XVRLCBPJGSBPDS-UHFFFAOYSA-N 0.000 description 1
- NUOYMOJXFODLFN-UHFFFAOYSA-N NCC(C1CCCCCCC1)O Chemical compound NCC(C1CCCCCCC1)O NUOYMOJXFODLFN-UHFFFAOYSA-N 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N c1ccccc1 Chemical compound c1ccccc1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/29—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
- C07C317/10—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/01—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton
- C07C323/02—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/07—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/16—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Definitions
- the invention relates to a process for the preparation of ⁇ , ⁇ -unsaturated sulfides, sulfones, sulfoxides and sulfonamides via intermediate ⁇ -ketosulfides, ⁇ -ketosulfones, ⁇ - ketosulfoxides and ⁇ -ketosulfonamides, respectively.
- Ar 1 and Ar 2 are independently selected from substituted and unsubstituted aryl and substituted and unsubstituted heteroaryl;
- X is N or CH; n is 0, 1 or 2, preferably 1 or 2, more preferably 2;
- R is -H or -(Ci-Cg)hydrocarbyl
- step (b) reacting said compound according to Formula III prepared in step (a), or a salt thereof, under conditions sufficient to dehydrate the secondary alcohol moiety of the Formula HI compound to form a compound according to Formula I, or a salt thereof;
- step (c) isolating said compound according to Formula I formed in step (b), or a salt thereof, from the reaction mixture of step (b).
- the compound according to Formula III, or a salt thereof may optionally be isolated prior to performing the dehydration reaction of Step (b), or the dehydration step may be carried out without isolation of the intermediate compound of Formula III.
- each R is independently selected from the group consisting of — H and -(Ci-C 8 )hydrocarbyl; each R 3 is independently selected from the group consisting of -(Ci-Cs)hydrocarbyl, -O(Ci-C 8 )hydrocarbyl, substituted and unsubstituted aryl, substituted and unsubstituted heterocyclyl(Ci-C 3 )alkyl, substituted and unsubstituted heteroaryl(Ci-C 3 )alkyl, -(C 2 -Cio)heteroalkyl, -(Ci-C 6 )haloalkyl, -CR 2 R 4 NHR 5 , -NR 2 2 , -(Ci-C 3 )alkyleneNH 2 , -(Ci-C 3 )alkylene-N((Ci-C 3 )alkyl) 2 ,
- each R 4 is independently selected from the group consisting of -H, -(Ci-Ce)alkyl,
- each R 5 is independently selected from the group consisting of -H,
- Substituents on substituted aryl or heteroaryl groups that comprise R 3 or R 7 are preferably independently selected from the group consisting of
- Ar 1 is phenyl.
- Ar 2 is phenyl.
- both Ar 1 and Ar 2 are phenyl.
- both Ar 1 and Ar 2 are at least mono-substituted.
- the aryl and heteroaryl groups comprising Ar 1 and Ar 2 are mono-, di- or tri-substituted. According to other embodiments, the aryl and heteroaryl groups comprising Ar 1 and Ar 2 are substituted at all substitutable positions.
- R is preferably -H or -(Ci-Cs)alkyl, more preferably -H or -(CrC 6 )alkyl, most preferably -H.
- the compound according to Formula I which is prepared according to the process of the invention is selected from the group consisting of: (£)-5-((2,4,6-trimethoxystyrylsulfonamido)-2- methoxyphenol; 5-( ⁇ [(l£T)-2-(2,4,6-trimethoxyphenyl)vinyl]sulfonyl ⁇ amino)-2- methoxyphenylamine; 2-[5-( ⁇ [(l£)-2-(2,4,6-trimethoxyphenyl)vinyl]sulfonyl ⁇ amino)-2- methoxy-phenylamino] acetic acid; (£)-N-phenyl-4-fiuorostyrylsulfonamide; (E)-N- phenyl-4-iodostyrylsulfonamide; (£)-N-phenyl-4-chlorostyrylsulfonamide; (E)-N-A- me
- compounds of Formula I wherein X is CH and n is 1 ( ⁇ , ⁇ -unsaturated sulfoxides) and compounds of Formula I wherein X is CH and n is 2 ( ⁇ , ⁇ -unsaturated sulfones), or salts thereof may be prepared by oxidation processes wherein compounds according to Formula I, wherein n is 0, or salts thereof, are used as chemical intermediates.
- Ar 1 and Ar 2 are independently selected from substituted and unsubstituted aryl and substituted and unsubstituted heteroaryl;
- X is CH; n is 1;
- R is -H or -(Ci-C 8 )hydrocarbyl
- a compound according to Formula I, or a salt thereof wherein: Ar 1 and Ar 2 are independently selected from substituted and unsubstituted aryl and substituted and unsubstituted heteroaryl;
- X is CH; n is 2; R is -H or -(Q-Cs ⁇ ydrocarbyl; and
- compounds according to Formula II, or salts thereof may be prepared, for example, by reacting a compound according to Formula Hc, or a salt thereof:
- a compound according to Formula lie wherein X is N and n is 2, or a salt thereof, may be prepared, for example, by a process comprising the steps of: (a) reacting a compound according to Formula He, or a salt thereof:
- R e is -(Ci-Cg)alkyl and L is a leaving group, preferably a halogen, more preferably -Cl or -Br; to form a compound according to Formula Hg, or a salt thereof:
- Reagents suitable for hydrolysis of a Formula Hg compound include, for example one or more bases, preferably alkali metal hydroxides, carbonates or bicarbonates or alkaline earth metal hydroxides, carbonates or bicarbonates, more preferably, alkali metal hydroxides such as, for example, LiOH and NaOH.
- Hydrolysis of a Formula Hg compound is preferably carried out in the presence of an aqueous solvent, more preferably a mixture of water with one or more water- miscible solvents selected from the group consisting of methanol, ethanol, acetonitrile, and tetrahydrofuran.
- an aqueous solvent more preferably a mixture of water with one or more water- miscible solvents selected from the group consisting of methanol, ethanol, acetonitrile, and tetrahydrofuran.
- a compound according to Formula lie wherein X is CH and n is 0, or a salt thereof, may be prepared, for example, by a process comprising the steps of: (a) reacting a compound according to Formula lib, or a salt thereof:
- R e is -(Ci-C 6 )alkyl and L is a leaving group, preferably a halogen, more preferably -Cl or -Br; to form a compound according to Formula Hi, or a salt thereof:
- step (b) hydrolyzing the compound according to Formula Hi, formed in step (a), or a salt thereof, to form a compound according to Formula Hc, wherein X is CH and n is 0, or a salt thereof.
- Reagents and solvents suitable for hydrolysis of a Formula Hi compound are as described above for hydrolysis of a Formula Hg compound.
- Compounds according to Formula He wherein X is CH and n is 1, or salts thereof, may be prepared, for example, by a process comprising reacting a compound according to Formula Hc, wherein X is CH and n is 0, or a salt thereof, with an oxidizing agent capable of oxidizing a sulfide to a sulfoxide to form a compound according to
- Compounds according to Formula He wherein X is CH and n is 2, or salts thereof, may be prepared, for example, by a process comprising reacting a compound according to Formula lie, wherein X is CH and n is 0, or a salt thereof, with an oxidizing agent capable of oxidizing a sulfide to a sulfone to form a compound according to
- compounds according to Formula II, wherein X is CH and n is 0, and salts thereof may be prepared, for example, by a process comprising the steps of: »
- Ar 2 is as defined as for compounds of Formula I, and L is a leaving group, with a compound according to Formula lib, or a salt thereof: lib wherein X is CH, and Ar 1 , * and R are as defined above for compounds according to Formula I; to form a compound according to Formula II, wherein X is CH and n is 0, or a salt thereof.
- the compound according to Formula II, or a salt thereof may optionally be isolated prior to proceeding with the use of the compound of Formula II in preparation of a compound according to Formula I.
- the process of preparing a compound according to Formula I, or a salt thereof may be carried out without isolation of the intermediate compound of Formula II.
- X is CH. According to some embodiments of the invention wherein X is CH, n is 0. According to other embodiments of the invention wherein X is CH, n is 1. According to still other embodiments of the invention wherein X is CH, n is 2.
- compounds according to Formula II, wherein X is CH and n is 1, or salts thereof may be prepared, for example, by a process comprising the steps of:
- step (b) reacting the compound according to Formula II formed in step (a), or a salt thereof, with an oxidizing agent capable of oxidizing a sulfide to a sulfoxide to form a compound according to Formula II, wherein X is CH and n is 1, or a salt thereof.
- the compound according to Formula II formed in step (a), or a salt thereof may optionally be isolated prior to reacting with an oxidizing agent in step (b), or the oxidation of step (b) may be done without isolation of the intermediate compound of Formula EL
- Formula II wherein X is CH and n is 2, or salts thereof, may be prepared, for example, by a process comprising the steps of:
- Ar 2 is as defined as for compounds of Formula I, and L is a leaving group; with a compound according to Formula Hb, or a salt thereof: ⁇ b wherein X is CH, and Ar 1 , * and R are as defined above for compounds according to Formula I, to form a compound according to Formula II, wherein X is CH and n is 0, or a salt thereof; and
- step (b) reacting the compound according to Formula II formed in step (a), or a salt thereof, with an oxidizing agent capable of oxidizing a sulfide to a sulfone to form a compound according to Formula II, wherein X is CH and n is 2, or a salt thereof.
- a compound according to Formula IA i.e. a compound of Formula I wherein X is CH and n is 0
- a salt thereof i.e. a compound of Formula I wherein X is CH and n is 0
- Ar 1 and Ar 2 are independently selected from substituted aryl and substituted or unsubstituted heteroaryl;
- R is -H or -(Ci-Cs)hydrocarbyl; * indicates that, when R is other than -H, the configuration of the substituents on the carbon atom of X is (R)-, (S)- or any mixture of (R)- and (S)-.
- each R 4 is independently selected from the group consisting of -H, -(Ci-C 6 )alkyl,
- each R 5 is independently selected from the group consisting of -H,
- Substituents on substituted aryl or heteroaryl groups that comprise R 3 or R 7 are preferably independently selected from the group consisting of -(Ci-C 6 )alkyl,
- substituents on Ar 1 are selected from the group consisting of -OR 2 , -NR 2 2 , and -NH-CR 2 R 4 -C(O)R 6 ; and substituents on Ar 2 are selected from the group consisting of -OR 2 .
- one of Ar 1 and Ar 2 is substituted phenyl. More preferably, for intermediates according to Formula IA, both Ar 1 and Ar 2 are substituted phenyl.
- Other intermediates of Formula IA are those wherein the aryl and heteroaryl groups comprising Ar 1 and Ar 2 are mono-, di- or tri-substituted. In other embodiments, the aryl and heteroaryl groups comprising Ar 1 and Ar 2 are substituted at all substitutable positions.
- Ar 1 is substituted at the 3- and 4- positions.
- Ar 2 is substituted at the 2- and 6- positions. According to other preferred embodiments, Ar 2 is substituted at the 2-, 4- and 6-positions.
- R is preferably -H or -(Ci-C 8 )alkyl, more preferably -H or -(Ci-Ce)alkyl, most preferably -H;
- R 2 is preferably -H or -(Ci-C 3 )alkyl, more preferably -H or -CH 3 , most preferably -H;
- R 4 is preferably -H, phenyl or -(Ci-Ce)alkyl; more preferably -H, phenyl or -(Ci-C 3 )alkyl, most preferably -H, -CH 3 or phenyl; and
- R 6 is preferably -OR 2 .
- Preferred compounds according to Formula IA include: ( ⁇ -5-((2,4,O- trimethoxystyrylthio)methyl)-2-methoxyphenol; (£)-2-(5-((2,4,6-trimethoxystyrylthio)- methyl)-2-methoxyphenylamino)propanoic acid; (£)-5-((2,4,6-trimethoxystyryl- thio)methyl)-2-methoxybenzenamine; (£)-2-(5-((2,4,6-trimethoxystyrylthio)methyl)-2- methoxyphenylamino)acetic acid; (£)-(4-fluorostyryl)(benzyl)sulfane; (E) ⁇ (4- iodostyryl)(benzyl)sulfane; (£)-(4-chlorostyryl)(benzyl)sulfane; (£)-(4-chlorostyryl)(4- methoxybenz
- Ar and Ar are independently selected from substituted and unsubstituted aryl and substituted and unsubstituted heteroaryl;
- X is N or CH;
- n is 0, 1 or 2;
- R is -H or -(Ci-C 8 )hydrocarbyl;
- J indicates that the configuration of the substituents on the designated carbon atom is (R)-, (S)- or any mixture of (R)- and (S)-; provided that: when X is N, then n is 2; when X is N and Ar 2 is unsubstituted phenyl, then Ar is substituted by other than -OH, -O(Ci-C 6 )alkyl, -NH 2 or -N((Ci-C 6 )alkyl) 2 ; and when Ar 2 is unsubstituted phenyl, then Ar 1 is other than 4-(Ci-C 6 )alkoxyphenyl.
- Preferred substituents on substituted aryl or heteroaryl Ar 1 and Ar 2 are as defined herein for compounds according to Formula I.
- Ar 1 is substituted or unsubstituted phenyl, more preferably substituted phenyl.
- Ar 2 is substituted or unsubstituted phenyl, more preferably substituted phenyl.
- both Ar 1 and Ar 2 are substituted or unsubstituted phenyl, more preferably substituted phenyl.
- Preferred compounds according to Formula III include: 5-((2-hydroxy-2-(2,4,6- trimethoxyphenyl)ethylsulfonyl)methyl)-2-methoxyphenol; 2-(5-((2-hydroxy-2-(2,4,6- trimethoxyphenyl)ethylsulfonyl)methyl)-2-methoxyphenylamino)propanoic acid; 2-(3- amino-4-methoxybenzylsulfonyl)-l-(2,4,6-trimethoxyphenyl)ethanol; 2-(5-((-2-hydroxy-
- the configuration of the substituents on the carbon atom designated by J is (R)-, and the compound is substantially free of the corresponding (S)-enantiomer of the same compound; or is (S)-, and the compound is substantially free of the corresponding (R)- enantiomer of the same compound.
- the compound comprises an (R)-enantiomer with respect to the absolute configuration at the carbon designated by J, and is substantially free of the corresponding (Sj-enantiomer of the same compound.
- the compound comprises an (Sj-enantiomer with respect to the absolute configuration at the carbon designated by J, and is substantially free of the corresponding (Rj-enantiomer of the same compound.
- alkyl by itself or as part of another substituent means, unless otherwise stated, a straight, branched or cyclic chain saturated hydrocarbon radical, including di- and multi-radicals, having the number of carbon atoms designated in an expression such as (C x -C y )alkyl.
- (C x -C y )allcyl wherein x ⁇ y, represents an alkyl chain containing a minimum of x carbon atoms and a maximum of y carbon atoms.
- Examples include: methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t- butyl, pentyl, neopentyl, hexyl, cyclohexyl and cyclopropylmethyl.
- Preferred is (C 1 - C 3 )alkyl, particularly ethyl, methyl and isopropyl.
- cycloalkyl refers to alkyl groups that contain at least one cyclic structure. Examples include cyclohexyl, cyclopentyl, norbomyl, adamantyl and cyclopropylmethyl.
- alkylene refers to a divalent alkyl radical having the number of carbon atoms designated, i.e.
- (Ci-C 6 ) means -CH 2 -; -CH 2 CH 2 -; -CH 2 CH 2 CH 2 -; -CH 2 CH 2 CH 2 CH 2 -; -CH 2 CH 2 CH 2 CH 2 -; and -CH 2 CH 2 CH 2 CH 2 CH 2 - and also includes branched divalent structures such as, for example, -CH 2 CH(CHs)CH 2 CH 2 - and -CH(CH 3 )CH(CH 3 )-, and divalent cyclic structures such as, for example 1,3-cyclopentyl.
- arylene by itself or as part of another substituent means, unless otherwise stated, a divalent aryl radical.
- heteroarylene by itself or as part of another substituent means, unless otherwise stated, a divalent heteroaryl radical. Preferred are five- or six-membered monocyclic heteroarylene. More preferred are heteroarylene moieties comprising divalent heteroaryl rings selected from the group consisting of pyridine, piperazine, pyrimidine, pyrazine, furan, thiophene, pyrrole, thiazole, imidazole and oxazole, such as, for example 2,5-divalent pyrrole, thiophene, furan, thiazole, oxazole, and imidazole.
- alkoxy employed alone or in combination with other terms means, unless otherwise stated, an alkyl group having the designated number of carbon atoms, as defined above, connected to the rest of the molecule via an oxygen atom, such as, for example, methoxy, ethoxy, 1-propoxy, 2-propoxy (isopropoxy) and the higher homologs and isomers.
- oxygen atom such as, for example, methoxy, ethoxy, 1-propoxy, 2-propoxy (isopropoxy) and the higher homologs and isomers.
- the carbon chains in the alkyl and alkoxy groups which may occur in the compounds of the invention may be cyclic, straight or branched, with straight chain being preferred.
- the expression "(CrC 6 )alkyl” thus extends to alkyl groups containing one, two, three, four, five or six carbons.
- the expression "(Ci-Cg)alkoxy” thus extends to alkoxy groups containing one, two, three, four, five or six carbons.
- hydrocarbyl refers to any moiety comprising only hydrogen and carbon atoms.
- the term includes, for example, alkyl, alkenyl, alkynyl, aryl and benzyl groups. Preferred are (Ci-C 7 )hydrocarbyl. More preferred are (Ci-C ⁇ )alkyl and
- heteroalkyl by itself or in combination with another term means, unless otherwise stated, a stable straight or branched chain radical consisting of the stated number of carbon atoms and one or two heteroatoms selected from the group consisting of O, N, and S, and wherein the nitrogen and sulfur atoms may be optionally oxidized and the nitrogen heteroatom may be optionally quaternized.
- the heteroatom(s) may be placed at any position of the heteroalkyl group, including between the rest of the heteroalkyl group and the fragment to which it is attached, as well as attached to the most distal carbon atom in the heteroalkyl group. Examples include: -0-CH 2 -CH 2 -CH 3 , -
- Up to two heteroatoms may be consecutive, such as, for example, -CH 2 -NH-OCHs, or -
- halo or halogen by themselves or as part of another substituent mean, unless otherwise stated, a fluorine, chlorine, bromine, or iodine atom.
- aromatic refers to a carbocycle or heterocycle having one or more polyunsaturated rings having aromatic character (4n + 2) delocalized ⁇ (pi) electrons).
- aromatic is intended to include not only ring systems containing only carbon ring atoms but also systems containing one or more non-carbon atoms as ring atoms. Systems containing one or more non-carbon atoms may be known as "heteroaryl" or
- heteromatic systems.
- aromatic thus is deemed to include “aryl”
- heteroaryl ring systems
- electrophilic acylation refers to an electrophilic aromatic substitution reaction wherein the electrophilic reagent is a carbonyl compound such as, for example, a carboxylic acid, a carboxylic acid halide are an acid anhydride.
- the electrophilic acylation is generally a "Friedel Crafts” acylation. A Friedel Crafts acylation may be catalyzed by a Lewis Acid or by a mineral acid.
- Lewis acid refers to a substance that acts as an electron-pair acceptor. Examples include, but are not limited to, AlCl 3 , BF 3 , BCl 3 , SnCl 2 , ZnBr 2 , ZnCl 2 , Al(Ci-C 6 alkyl) 3 , AlCl(Ci-C 6 alkyl) 2 , and AlCl 2 (Ci-C 6 alkyl).
- the expression “leaving group” refers to an atom, or a group of atoms, that is displaced from a molecule as stable species during a chemical reaction, particularly a nucleophilic displacement reaction. The leaving group takes with it the bonding electrons from the bond connecting the leaving group to the molecule from which it is displaced. The leaving group is generally an anion, e.g. CF or CH 3 SO 3 " .
- a “mineral acid” is generally a strong acid such as, for example, HCl, HBr, H 2 SO 4 , or HNO 3 .
- aryl employed alone or in combination with other terms, means, unless otherwise stated, a carbocyclic aromatic system containing one or more rings (typically one, two or three rings) wherein such rings may be attached together in a pendent manner, such as a biphenyl, or may be fused, such as naphthalene. Examples include phenyl, anthracyl, and naphthyl which may be substituted or unsubstituted. The aforementioned listing of aryl moieties is intended to be representative, not limiting.
- heterocycle or “heterocyclyl” or “heterocyclic” by itself or as part of another substituent means, unless otherwise stated, an unsubstituted or substituted, stable, monocyclic or polycyclic heterocyclic ring system which consists of carbon atoms and at least one heteroatom selected from the group consisting of N, O, and S, and wherein the nitrogen and sulfur heteroatoms may be optionally oxidized, and the nitrogen atom may be optionally quaternized.
- the heterocyclic system may be attached, unless otherwise stated, at any heteroatom or carbon atom which affords a stable structure.
- Heterocyclyl groups are inclusive of monocyclic and polycyclic heteroaryl groups and monocyclic and polycyclic groups that are not aromatic, such as saturated and partially saturated and monocyclic and polycyclic partially saturated monocyclic and polycyclic groups.
- heteroaryl or “heteroaromatic” refers to a heterocycle having aromatic character, and includes both monocyclic heteroaryl groups and polycyclic heteroaryl groups.
- a polycyclic heteroaryl group may include one or more rings which are partially saturated.
- Examples of monocyclic heteroaryl groups include: pyridyl; pyrazinyl; pyrimidinyl, particularly 2- and 5-pyrirnidinyl; pyridazinyl; thienyl; furyl; pyrrolyl, particularly 2-pyrrolyl and l-alkyl-2-pyrrolyl; imidazolyl, particularly 2-imidazolyl; thiazolyl, particularly 2-thiazolyl; oxazolyl, particularly 2-oxazolyl; pyrazolyl, particularly 3- and 5-pyrazolyl, isothiazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, 1,3,4- triazolyl, tetrazolyl, 1,2,3-thiadiazolyl, 1,2,3-oxadiazolyl, 1,3,4-thiadiazolyl; and 1,3,4- oxadiazolyl.
- monocyclic heterocycles that are not aromatic include saturated monocyclic groups such as: aziridine, oxirane, thiirane, azetidine, oxetane, thietane, pyrrolidine, pyrroline, imidazoline, pyrazolidine, dioxolane, 1,4-dioxane, 1,3-dioxane, sulfolane, tetrahydrofuran, thiophane, piperazine, morpholine, thiomorpholine, tetrahydropyran, homopiperazine, homopiperidine, 1,3-dioxepane, hexamethyleneoxide and piperidine; and partially saturated monocyclic groups such as: 1,2,3,6- tetrahydropyridine, 1,4-dihydropyridine, 2,3-dihydrofuran, 2,5-dihydrofuran, 2,3- dihydropyran, 1,2-dihydrothiazo
- 6- and 7-indolyl quinolyl, isoquinolyl, particularly 1- and 5-isoquinolyl, cinnolinyl, quinoxalinyl, particularly 2- and 5-quinoxalinyl, quinazolinyl, phthalazinyl, 1,8- naphthyridinyl, 1,4-benzodioxanyl, coumarin, benzofuryl, particularly 3-, A-, 1,5- naphthyridinyl, 5-, 6- and 7-benzofuryl, 1,2-benzisoxazolyl, benzothienyl, particularly 3- , A-, 5-, 6-, and 7-benzothienyl, benzoxazolyl, benzthiazolyl, particularly 2- benzothiazolyl and 5-benzothiazolyl, purinyl, benzimidazolyl, particularly 2- benzimidazolyl, benztriazolyl, thioxanthinyl, carbazolyl, carbolinyl, acri
- Preferred heteroaryl groups are 2-, 3- and 4-pyridyl; pyrazinyl; 2- and 5- pyrimidinyl; 3-pyridazinyl; 2- and 3-thienyl; 2- and 3-furyl; pyrrolyl; particularly N- methylpyrrol-2-yl; 2-imidazolyl; 2-thiazolyl; 2-oxazolyl; pyrazolyl; particularly 3- and 5- pyrazolyl; isothiazolyl; 1,2,3-triazolyl; 1 ,2,4-triazolyl; 1,3,4-triazolyl; tetrazolyl, 1,2,3- thiadiazolyl; 1,2,3-oxadiazolyl; 1,3,4-thiadiazolyl and 1,3,4-oxadiazolyl; indolyl, particularly 2-, 3-, A-, 5-, 6- and 7-indolyl; cinnolinyl; quinoxalinyl, particularly 2- and 5- quinoxalinyl; quin
- heteroaryl groups are 2, 3- and 4-pyridyl; 2- and 3-thienyl; 2- and 3-furyl; 2-pyrrolyl; 2-imidazolyl; 2-thiazolyl; 2-oxazolyl; 2- and 3-indolyl; 2-, and 3- benzofuryl; 3-(l,2-benzisoxazolyl); 2-, and 3 -benzothienyl; 2-benzoxazolyl; 1- and 2- benzimidazolyl, 2-, 3- and 4-quinolyl; and 2- and 5 -benzthiazolyl.
- Most preferred heteroaryl groups are 2- and 3-indolyl; 2- and 3-pyrrolyl, 2-, and 3-benzofuryl; and 2-, and 3 -benzothienyl.
- substituted means that an atom or group of atoms has replaced hydrogen as the substituent attached to another group.
- substituted refers to any level of substitution, namely mono-, di-, tri-, terra-, or penta-substitution, where such substitution is permitted.
- the substituents are independently selected, and substitution may be at any chemically accessible position.
- the ⁇ , ⁇ -unsaturated sulfides, sulfones, sulfoxides and sulfonamides are characterized by isomerism resulting from the presence of a double bond.
- This isomerism is commonly referred to as cis-trans isomerism, but the more comprehensive naming convention employs E and Z designations.
- the compounds are named according to the Cahn-Ingold-Prelog system, the IUPAC 1974 Recommendations, Section E: Stereochemistry, in Nomenclature of Organic Chemistry, John Wiley & Sons, Inc., New York, NY, 4 th ed., 1992, p. 127-138.
- Some of the sulfides, sulfones, sulfoxides and sulfonamides according to Formulae I and III may be characterized by isomerism resulting from the presence of a chiral center at X, when X is CH and R is other than -H.
- Compounds according to Formula III have a chiral center at the carbon designated by %.
- the isomers resulting from the presence of a chiral center comprise a pair of non-superimposable isomers that are called "enantiomers.”
- Single enantiomers of a pure compound are optically active, i.e., they are capable of rotating the plane of plane polarized light.
- Single enantiomers are designated according to the Cahn-Ingold-Prelog system. See March, Advanced Organic Chemistry, 4 th Ed., (1992), p. 109. Once the priority ranking of the four groups is determined, the molecule is oriented so that the lowest ranking group is pointed away from the viewer. Then, if the descending rank order of the other groups proceeds clockwise, the molecule is designated (R) and if the descending rank of the other groups proceeds counterclockwise, the molecule is designated (S). In the example shown in Scheme 2 below, the Cahn-Ingold-Prelog ranking is A > B > C > D. The lowest ranking atom, D is oriented away from the viewer.
- substantially free of the (R)- or (iS)-enantiomer when used to refer to an optically active compound according to Formula in, means the (R)- and (S)- enantiomers of the compound have been separated such that the composition is 80% or more by weight a single enantiomer.
- the composition is 90% or more by weight a single enantiomer. More preferably, the composition is 95% or more by weight a single enantiomer. Most preferably, the composition is 99% or more by weight a single enantiomer.
- an "(i?)-enantiomer of a compound according to Formula III substantially free of the ()5)-enantiomer is meant the compound comprises 80% or more by weight of its (i ⁇ )-enantiomer and likewise contains 20% or less of its (>S)-enantiomer as a contaminant, by weight.
- Isolated optical isomers may be purified from racemic mixtures by well-known chiral separation techniques. According to one such method, a racemic mixture of a compound having the structure of Formula I, or a chiral intermediate thereof, is separated into 99% wt.% pure optical isomers by HPLC using a suitable chiral column, such as a member of the series of DAICEL ® CHIRALP AK ® family of columns (Daicel
- Formula III may be prepared by chiral reduction of intermediate ketone compounds according to Formula II.
- Catalytic asymmetric synthesis using chiral metal complexes as catalyst precursors has been employed successfully to reduce prochiral ketones to optically active secondary alcohols. See, Noyori R., Asymmetric Catalysis in Organic Synthesis, New York, John Wiley, 1994, pages 1-82, the entire disclosure of which is incorporated herein by reference.
- more than one chiral center may be present in a molecule, i.e., the carbon atom of X when X is CH and R is other than -H, and the carbon atom designated by J.
- Two pairs of enantiomers result from the presence of two chiral centers. Only the relationship between the mirror-image isomers is termed enantiomeric. The relationship between a single enantiomer and other isomers that exist as a result of additional chiral centers is termed "diastereomeric.” Diastereomeric pairs may be resolved by known separation techniques including normal and reverse phase chromatography, and crystallization.
- Nomenclature employed herein for providing systematic names for compounds disclosed herein may be derived using the computer program package, CHEMDRAW ® , CambridgeSoft Corporation, Cambridge, MA 02140.
- Preparation of the compounds of Formula I by the process of the present invention comprises reduction of a ⁇ -ketosulfide, ⁇ -ketosulfoxide, ⁇ -ketosulfone, or ⁇ - ketosulfonamide compound of Formula II to form a secondary alcohol of Formula III.
- This step is followed by dehydration of the alcohol of Formula III to form a compound according to Formula I.
- Reducing a compound of Formula II to yield a secondary alcohol of Formula III may be performed by reacting the Formula II compound with a suitable reducing agent under reaction conditions capable of selectively reducing a ketone to the corresponding alcohol.
- the reducing agent and reaction conditions may further be selected to reduce other moieties present in the Formula II compound if the reduction of such additional moieties serves to allow the preparation of a specific desired compound of Fo ⁇ nula I.
- Suitable reducing agents include hydride reagents such as sodium borohydride, lithium aluminum hydride and sodium bis(2-methoxyethoxy)aluminum hydride.
- the reaction is preferably performed in the presence of a solvent.
- Suitable solvents include organic solvents such as, for example diethyl ether, t-butylmethyl ether, tetrahydrofuran (THF) and toluene.
- the reaction is preferably performed at a temperature in the range from about 0 0 C to about 100 0 C, more preferably from about 0 0 C to about 50 0 C, most preferably from about 0 0 C to about 30 0 C.
- the desired compound according to Formula II may be isolated from the reaction mixture by, for example, adding a suitable proton source, e.g., water, acetic acid, aqueous HCl, or aqueous NH 4 + Cl to the reaction mixture to quench any remaining hydride reagent, hydrolyzing intermediate metal species, removing the volatile components of the reaction mixture under vacuum and purifying the residue, e.g., by chromatographic separation.
- a suitable proton source e.g., water, acetic acid, aqueous HCl, or aqueous NH 4 + Cl
- Suitable conditions for reducing a compound of Formula II to yield a secondary alcohol of Formula III also include catalytic hydrogenation conditions.
- Suitable catalysts for catalytic hydrogenation include platinum palladium, ruthenium and nickel reagents.
- the reaction is preferably performed in the presence of a suitable solvent. Suitable solvents include alkyl alcohols such as methanol and ethanol, THF, and dioxane.
- the reaction is preferably performed at a hydrogen pressure in the range from about 1 to about 5 atmospheres, more preferably from 1 to 3 atmospheres.
- the reaction is preferably performed at a temperature in the range from about 0 °C to about 50 0 C, most preferably in the range form about 20 0 C to about 30 0 C.
- the desired compound according to Formula II may be isolated from the reaction mixture by, for example, removing the catalyst, preferably by filtration, concentrating the filtered reaction mixture to form a residue, and purifying the residue, e.g., by chromatographic separation.
- reaction conditions for performing catalytic hydrogenation are described by R. L. Augustine, Catalytic Hydrogenation, Marcel Dekker, Inc., New York (1965), and Paul N. Rylander, Catalytic Hydrogenation in Organic Synthesis, Academic Press, New York (1979) and the references cited therein, the entire disclosures of which are incorporated herein by reference.
- the reduction of a compound of Formula II to yield an optically active secondary alcohol of Formula III may be performed by using any reducing agent and reaction conditions capable of asymmetrically reducing a ketone to the corresponding optically active alcohol.
- Suitable reactions include, for example, catalytic hydrogenation with a chiral Rh(I), Ir(I), Ru(II), or lanthanoid complex as a catalyst precursor; hydrogen; and a chiral auxiliary and enantioselective hydroboration with reagents such as, for example, (+)-5-chlorodiisopinocampheylborane or (-)--5-chlorodiisopinocampheylborane.
- Suitable chiral auxiliaries for chiral catalytic reductions include, for example, BINAP (2,2'-bis-(diphenylphosphino)-l,r-bmaphthyi) or an analog thereof, and PNP (6-diphenylphosphinomethyl)-pyridine
- Preferred hydrogenation catalysts include, for example, Ru-(R)BINAP(Br) 2 , Ru-(R)BINAP(Cl) 2 , Ru-(S)BINAP(Br) 2 , Ru- (S)BINAP(Cl) 2 , Ru-(R)BINAP(OAc) 2 , and Ru-(S)BINAP(OAc) 2 .
- a suitable hydrogen pressure for the asymmetric reduction is preferably in the range from about 1 to about 100 atmospheres, more preferably from about 1 to about 70 atmospheres.
- the reaction is preferably performed at a temperature in the range from about 0 0 C to about 50 0 C, more preferably from about 20 0 C to about 30 0 C.
- Dehydrating a compound of Formula III to yield an ⁇ , ⁇ -unsaturated sulfone, sulfoxide or sulfonamide of Formula I may be performed by reaction with a suitable dehydrating agent under conditions capable of accomplishing such a dehydration.
- the dehydration of the Formula in compound may be performed by reacting the Formula III compound with a Lewis acid or a mixture of different Lewis acids.
- Preferred Lewis acids include BF 3 etherate, BCl 3 and aluminum chloride.
- the reaction is preferably performed in the presence of a suitable solvent, most preferably a solvent that forms a low boiling azeotrope with water.
- suitable solvents include, for example, non- protic solvents such as methyl acetate, ethyl acetate diethyl ether, THF, toluene, methylene chloride, chloroform or carbon tetrachloride.
- the reaction may be carried out at a temperature in the range, for example, from about -20 0 C to about 100 0 C, preferably in the range from about -20 0 C to about 25 0 C, most preferably in the range from about 0 0 C to about 10 0 C.
- the desired product of Formula I may be isolated from the dehydration reaction mixture, for example, by removing the volatile components of the reaction mixture under vacuum and purifying the residue by chromatographic separation.
- Dehydration of the alcohol of Formula III may also be accomplished by first derivatizing the -OH group, for example by acylation or halogenation, either prior to, or during, the dehydration reaction.
- the derivatized alcohol of Formula III then reacts to form the Formula I olefin by a ⁇ -elimination, e.g., dehydrohalogenation.
- Derivatization of the -OH group serves to replace -OH with a leaving group that is more reactive than -
- Suitable derivatizations of the -OH group of a compound of Formula III include, for example, acylation, e.g., acetylation; sulfonylation, e.g., tosylation; and halogenation, e.g. chlorination.
- Acylation of the -OH group of a Formula HI compound may be accomplished by reaction of the Formula HI compound with an acylating agent such as an anhydride, e.g., acetic anhydride or an acid halide, e.g., acetyl chloride.
- an acylating agent such as an anhydride, e.g., acetic anhydride or an acid halide, e.g., acetyl chloride.
- the acylation reaction is preferably performed in the presence of a suitable solvent.
- Suitable solvents include aprotic solvents such as, for example, THF or ether.
- Sulfonylation of the —OH group of a Formula III compound may be accomplished by reaction of the Formula III compound with an sulfonylating agent such as, for example, an anhydride, e.g., triflic anhydride or a sulfonic acid halide, e.g., tosyl chloride.
- an sulfonylating agent such as, for example, an anhydride, e.g., triflic anhydride or a sulfonic acid halide, e.g., tosyl chloride.
- the sulfonylation reaction is preferably performed in the presence of a suitable solvent.
- Suitable solvents include aprotic solvents such as, for example, THF or ether.
- Halogenation of the -OH group of a Formula III compound may be accomplished by reaction of the Formula III compound with an halogenating agent such as, for example, thionyl chloride or phosphorous oxychloride.
- the halogenation reaction is preferably performed in the presence of a suitable solvent.
- suitable solvents include aprotic solvents such as, for example, THF or ether.
- the halogenation reaction serves to replace the -OH group with a halogen.
- Dehydration of a compound according to Formula II, or a compound of Formula II derivatized, by acylation, sulfonylation or halogenation may be accomplished by reaction with a base such as triethylamine (TEA), N 1 N- diisopropylethylamine (DIEA) or diazabicycloundecene (DBU).
- a base such as triethylamine (TEA), N 1 N- diisopropylethylamine (DIEA) or diazabicycloundecene (DBU).
- TAA triethylamine
- DIEA N 1 N- diisopropylethylamine
- DBU diazabicycloundecene
- the reaction is preferably performed in the presence of a suitable solvent such as for example, methyl acetate, ethyl acetate diethyl ether, THF, toluene, methylene chloride, chloroform or carbon t
- One preferred method for the preparation of compounds according to Formula II is by electrophilic acylation of an aromatic compound comprising Ar 2 , according to Scheme 3.
- the reaction of a compound of Formula Hc and a compound of Formula Hd is preferably performed, according to Scheme 3, by adding a Lewis acid to a solution of the reactant compounds, and heating the resulting reaction mixture to a suitable reaction temperature.
- the reaction is preferably performed at a temperature in the range from about 50 0 C to about 200 0 C, preferably from about 80 0 C to about 150 0 C.
- the Formula Hd reactant is a liquid, it may be employed as the solvent in the reaction.
- Compounds of Formula Hd which may be employed as the solvent in the reaction include benzene, fiuorobenzene, chlorobenzene and anisole.
- a suitable solvent is preferably a high boiling solvent which is unreactive under the reaction conditions, e.g., nitrobenzene.
- Suitable Lewis acids include, for example, AlCl 3 , BF 3 , BCl 3 , ZnCl 2 , ZnBr 2 , and P 2 O 5 .
- a preferred preparation of the sulfide compounds according to Formula II proceeds, as shown in Scheme 4, by reacting an aromatic mercaptan according to Formula lib and a Formula IIa compound, wherein Ar 1 , Ar 2 , R, and * are defined as for Formula I, above, and X is CH.
- Preferred base addition salts of a compound of Formula lib are alkali metal salts or alkaline earth metal salts.
- the salt of the compound according to Formula lib may be prepared, for example, by contacting the compound of Formula lib with a solution of a base, e.g. sodium hydroxide in a suitable solvent.
- Suitable solvents include polar organic solvents which are capable of solvating the base, preferably a low boiling alcohol such as methanol or ethanol.
- the amount of solvent is preferably sufficient to achieve a concentration of the Formula lib compound in the range from about O.lM to about 0.3M, most preferably about 0.2M.
- about one equivalent of the base is used, based on the amount of the Formula Ha compound.
- the formation of the salt of the Formula lib compound is preferably performed at a temperature in the range from about 0 0 C to about 50 0 C, more preferably from about 0 0 C to about 30 0 C, most preferably at about 25 0 C.
- the compound according to Formula Ha comprises a leaving group, L.
- Preferred leaving groups are halogens and sulfonates, e.g., tosylate or mesylate.
- the Formula Ha compound is added to the Formula lib compound in portions or continuously over a suitable time interval.
- the time interval is from about 2 to about 60 minutes, more preferably from about 5 to about 30 minutes.
- the addition of the Formula Ha compound is preferably performed at a temperature in the range from about 0 0 C to about 50 0 C, more preferably from about 0 0 C to about 30 0 C, most preferably at about 25 0 C.
- the resulting reaction mixture is preferably heated to a suitable reaction temperature.
- a suitable temperature is preferably in the range from about 50 0 C to about 100 0 C, most preferably at about the boiling point of the reaction mixture.
- reaction mixture is maintained at the reaction temperature until the reaction is complete. Determination of the completion of the reaction may be determined by any reasonable means. Preferably, the reaction is monitored by thin layer chromatography (TLC) or by high performance liquid chromatography (HPLC).
- TLC thin layer chromatography
- HPLC high performance liquid chromatography
- the Formula H sulfide compound is preferably isolated by cooling the reaction mixture and pouring the reaction mixture onto ice or ice water to precipitate the product.
- the product Formula II sulfide compound may then be separated, e.g., by filtration and dried under vacuum.
- Formula II sulfoxide compounds and Formula II sulfone compounds may be prepared by oxidizing the Formula II sulfide compound. Oxidation to the sulfone compound of Formula II may be accomplished by reaction with any oxidizing agent and reaction conditions capable of oxidizing a sulfide to a sulfone. Suitable oxidizing reagents for both oxidation reactions include, for example, peroxides such as, hydrogen peroxide, peracids such as meta-chloroperoxybenzoic acid (MCPBA) and persulfates such as OXONE® (potassium peroxymonosulfate). The reaction is preferably carried out in the presence of a suitable solvent.
- Suitable solvents include, for example, water, acetic acid or non-polar solvents such as dichloromethane (DCM).
- Reaction to selectively form a Formula II sulfoxide compound is preferably performed at low temperature, more preferably from about -10 0 C to about 20 0 C.
- a reaction to form the Formula II sulfoxide compound is preferably monitored so as to terminate the reaction prior to appreciable oxidation to the corresponding sulfone.
- the reaction mixture may be poured onto crushed ice.
- a solid precipitate of the crude product may be collected by filtration and recrystallized from a suitable solvent such as, for example, hot water to yield the purified Fonnula II sulfoxide compound.
- Reaction to form the Formula II sulfone compound may be performed at higher temperature, for example, from about 20 0 C to about 100 0 C with an oxidizing agent such as, for example, 30% hydrogen peroxide in glacial acetic acid.
- an oxidizing agent such as, for example, 30% hydrogen peroxide in glacial acetic acid.
- the reaction mixture may be cooled to ambient temperature and poured onto crushed ice.
- a solid precipitate of the crude product may be collected by filtration and recrystallized from a suitable solvent such as, for example, hot water to yield the purified Formula II sulfone compound.
- any reactive groups present may be protected during a reaction by protecting groups.
- a "protecting group” is a chemical functionality which selectively blocks one or more reactive sites in a multifunctional compound such that a chemical reaction can be carried out selectively at another unprotected reactive site.
- Certain processes for preparation of compounds according to the present invention may rely upon protecting groups to block reactive functional groups that are present in the reactants. Examples of reactive groups which may be blocked by suitable protecting groups include -NH 2 or -OH groups which may be present, for example, on chemical intermediates according to Formula lib. If such groups were not blocked by suitable protecting groups prior to reaction with an intermediate according to Formula Ila, unwanted side reactions could occur.
- a side reaction is that a -NH 2 or -OH group on the Formula Hb compound may react with the Formula Ha intermediate in addition to, and in competition with the -SH group on the Formula lib compound.
- the protecting group may be introduced prior to carrying out a particular reaction that may affect a chemical group other than one that is desired.
- the protecting group is optionally removed at any suitable point in the synthesis after the reaction which required use of the protecting group.
- the desired product of Formula I may have an acetyl group on Ar 1 . If the intermediate of Formula II is substituted by an acetyl group and is reduced to form an intermediate of Formula III, the acetyl group on Ar will be reduced in the reaction.
- the intermediate of Formula II would be prepared with the acetyl group protected, for example as a ketal. The ketal will be unreactive under the conditions required to reduce the intermediate of Formula I to an intermediate of Formula III.
- Protecting groups may be chosen from any protecting groups described in the literature or known to the skilled chemist as suitable for the protection of the functional group which must be protected. Protecting groups may be introduced and removed by any suitable chemical synthesis method that is described in the art or known to the skilled chemist as suitable for the removal of the particular protecting group. Methods of removing protecting groups are preferably selected so as to effect selective removal of the protecting group with minimum effect on other chemical functionality in the molecule.
- Protecting groups for alcoholic or phenolic hydroxyl groups include, for example, acetates, haloalkyl carbonates, benzyl ethers, alkylsilyl ethers, heterocyclyl ethers, and methyl or alkyl ethers.
- Protecting groups for carboxyl groups include t-butyl, benzyl or methyl esters.
- Protecting groups for amine groups include benzyl, 2,4- dimethoxybenzyl, CBZ, p-methoxybenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, t- BOC, trifluoroacetyl.
- Methods for removal of hydroxy and amino protecting groups include, for example, acid, base, metal or enzyme-catalyzed hydrolysis for CBZ; acid or iodotrimethylsilane for removal of t-BOC groups; hydrogenation for benzyl and CBZ; and photolysis for o-nitrobenzyloxycarbonyl.
- Protecting groups may also include different oxidation states of a chemical group.
- An example of such a protecting group is a nitro group, which may readily be reduced to an amino group.
- the amino group may be reactive under the reaction conditions of a synthetic step whereas the corresponding nitro group may be inert to the reaction conditions.
- the synthetic step may be performed with a nitro group in the place of the amino group.
- the nitro group may be reduced to the desired amino group at a later point in the synthesis.
- Scheme 5 According to Scheme 5, (4-methoxy-3-nitrophenyl)methanethiol 1() (an aromatic mercaptan according to Formula lib) is reacted with 2-bromo-l -(2,4,6- trimethoxyphenyl)ethanone (a compound according to Formula Ha) to form 2-(4- methoxy-3-nitrobenzylthio)-l-(2,4,6-trimethoxyphenyl)ethanone 11 (a sulfide according to Formula II). Suitable reaction conditions for this reaction are as described above for the reaction of a Formula Ha compound and a Formula lib compound.
- Compound 11 is reacted with an oxidizing agent capable of oxidizing a sulfide to a sulfone, thereby forming 2-(4-methoxy-3-nitrobenzylsulfonyl)-l-(2,4,6- trimethoxyphenyl)ethanone 12 (a sulfone compound according to Formula II).
- Suitable oxidation conditions are as described above for the oxidation of a Formula II sulfide compound to a Formula II sulfone compound.
- Compound 12 is reacted under conditions sufficient to reduce the ketone moiety to a secondary alcohol thereby forming 2-(3-amino-4-methoxyben2ylsulfonyl)-l -(2,4,6- trimethoxyphenyl)ethanol, 13 (a compound according to Formula III).
- the reduction is performed under any conditions sufficient to reduce the ketone moiety of compound 12 to a secondary alcohol, and sufficient to reduce the nitro moiety of compound 12 to an amine.
- the reduction may be performed, for example, by hydrogenation in the presence of a hydrogenation catalyst.
- the hydrogenation is preferably carried out in the presence of a solvent. Suitable solvents include, for example, ethanol, methanol, THF, and acetic acid.
- Suitable hydrogenation catalysts include platinum, palladium, nickel and ruthenium catalysts.
- the hydrogenation reaction is preferably performed at a temperature in the range from about 0 0 C to about 100 0 C, more preferably from about 10 0 C to about 60 0 C, most preferably from about 20 0 C to about 30 0 C.
- the hydrogenation reaction is preferably performed at a hydrogen pressure in the range from about 1 to about 100 atmospheres, more preferably from about 1 to about 10 atmospheres, most preferably from about 1 to about 3 atmospheres.
- reduction of the ketone moiety and the nitro moiety of compound 12 may be performed as separate reaction steps.
- the ketone moiety may be reduced by reaction with a hydride reagent such as sodium borohydride, lithium aluminum hydride and sodium bis(2-methoxyethoxy)aluminum hydride as described herein.
- the nitro moiety may be reduced, for example by catalytic hydrogenation as described above, or by other procedure such as, for example reaction with zinc and acetic acid, or tin and aqueous HCl, or by other methods of aromatic nitro group reduction known in the art.
- Compound 13 is reacted under conditions sufficient to dehydrate the secondary alcohol moiety of compound 13 to form (£)-5-((2,4,6-trimethoxystyrylsulfonyl)methyl)-
- 2-methoxybenzenamine, 14 (a compound according to Formula I). Suitable conditions under which compound 13 may be dehydrated to form compound 14 are as described above for the dehydration of a Formula HI compound to form a Formula I compound.
- a benzyl or substituted benzyl mercaptan 1 (10 mmol) is added slowly to a solution of sodium hydroxide (10 mmol) in methanol (50 mL) at ambient temperature (25 0 C) to form a solution.
- a phenacyl or substituted phenacyl bromide 2 (10 mmol) is added, portion-wise, a phenacyl or substituted phenacyl bromide 2 (10 mmol).
- the resulting mixture is heated at reflux temperature with stirring for 8 hours.
- the reaction is monitored by TLC to determine when the reaction is complete.
- the solution is then cooled to ambient temperature (25 0 C) and poured onto crushed ice (about 200 g).
- Step B Preparation of substituted phenacyl arylmethanesulfone 4:
- phenacyl arylmethanesulfide 3 To a solution of phenacyl arylmethanesulfide 3 (5g) in glacial acetic acid (40 mL), is added 30% hydrogen peroxide (10 mL). The resulting solution is stirred at ambient temperature (25 0 C) for 8 hours. The reaction is monitored by TLC to determine when the reaction is complete. When the reaction is complete, the solution is then poured onto crushed ice (about 200 g). A solid precipitates and is separated by filtration. The separated solid is recrystallized from 2-propanol to yield the purified product phenacyl arylmethanesulfone 4.
- the intermediate phenacyl arylmethanesulfone 4 is a compound according to Formula H.
- Step C Preparation of l-Aryl-2-arylmethanesulfonyl-ethanol 5: To a solution of phenacyl arylmethanesulfone 4 (10 mmol) in tetrahydrofuran (30 mL) is added sodium borohydride (20 mmol). The resulting mixture is stirred for 8 h at ambient temperature (25 0 C). The reaction is monitored by TLC to determine when the reaction is complete. After completion of the reaction, the solvent is removed under vacuum to form a residue. Water (200 mL) is added to the residue. A solid precipitate forms.
- Step Dl Preparation of CEVstyryl benzylsulfone 6 (Method 1): Boron trifluoride etherate (5 mmol) is added to an acetic anhydride (10 mL) solution of the l-aryl-2-arylmethanesulfonyl-ethanol 5 (5 mmol) at 0 0 C. The resulting mixture is stirred for 0.5 h. The mixture is then poured into chloroform (25 mL). The organic layer is separated. The organic layer is washed with saturated aqueous NaHCO 3 (2 x 25 mL), and water (2 x 25 mL). The organic layer is then dried over sodium sulfate, filtered and concentrated under vacuum to yield a residue. The residue is recrystallized from 2-propanol to yield the desired (i ⁇ )-styryl ben ⁇ ylsulfone product 6.
- Example 1 The compounds of Examples 1 - 6 were prepared according to the procedures of Steps A, B, C, Dl and D2. Table 1 lists the intermediate phenacyl arylmethanesulfones 4 which were prepared according to Step B as intermediates in the preparation of the compounds of Examples 1-6.
- Table 2 lists the intermediate l-aryl-2-arylmethanesulfonyl-ethanols 5 prepared according to Step C as intermediates in the preparation of the compounds of Examples 1- 6.
- Table 3 lists the (£)-styryl benzylsulfone products 6 which were prepared according to Step Dl.
- Benzyl sulfonyl acetic acid 7 (4.1 mmol) is added to a phenyl compound 8 (30 mL). To this mixture is added phosphorous pentoxide (4.0 g). The resulting reaction mixture is heated to 81° C and maintained at that temperature until the reaction is complete. The reaction is monitored by TLC. When the reaction is complete by TLC analysis, the reaction mixture is cooled to ambient temperature (25 0 C). Dichloromethane (25 mL) is added to the cooled reaction mixture. A viscous solid precipitate forms. The precipitate is separated by filtration. The precipitate is washed with dichloromethane (2 x 50 mL). The filtrate and the dichloromethane washes are combined and concentrated under vacuum to yield a residue. The residue is purified by column chromatography to yield the purified phenacyl arylmethanesulfone compound 4 according to Formula II.
- Table 4 lists the intermediate phenacyl arylmethanesulfones 4 which were prepared according to Step A2 as chemical intermediates.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/884,601 US8143453B2 (en) | 2005-02-25 | 2006-02-24 | Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
EP06736103.0A EP1896401B1 (en) | 2005-02-25 | 2006-02-24 | Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
PL06736103T PL1896401T3 (en) | 2005-02-25 | 2006-02-24 | Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
SI200631592T SI1896401T1 (en) | 2005-02-25 | 2006-02-24 | Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
ES06736103T ES2417135T3 (en) | 2005-02-25 | 2006-02-24 | Synthesis of sufuros, sulfones, sulfoxides and unsaturated sulfonamides |
CA2599169A CA2599169C (en) | 2005-02-25 | 2006-02-24 | Synthesis of (e)-alpha, beta unsaturated sulfides, sulfones, sulfoxides and sulfonamides |
AU2006216544A AU2006216544B2 (en) | 2005-02-25 | 2006-02-24 | Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
DK06736103.0T DK1896401T3 (en) | 2005-02-25 | 2006-02-24 | Synthesis of unsaturated sulfides, sulfones, sulfoxides and sulfonamides |
IL185400A IL185400A (en) | 2005-02-25 | 2007-08-20 | (e) -alpha, beta unsaturated sulfides, sulfones, sulfoxides and sulfonamides, process for the preparation thereof and an intermediate |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65620405P | 2005-02-25 | 2005-02-25 | |
US60/656,204 | 2005-02-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006091870A2 true WO2006091870A2 (en) | 2006-08-31 |
WO2006091870A3 WO2006091870A3 (en) | 2007-01-18 |
Family
ID=36928071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/006698 WO2006091870A2 (en) | 2005-02-25 | 2006-02-24 | Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
Country Status (11)
Country | Link |
---|---|
US (1) | US8143453B2 (en) |
EP (1) | EP1896401B1 (en) |
AU (1) | AU2006216544B2 (en) |
CA (1) | CA2599169C (en) |
DK (1) | DK1896401T3 (en) |
ES (1) | ES2417135T3 (en) |
IL (1) | IL185400A (en) |
PL (1) | PL1896401T3 (en) |
PT (1) | PT1896401E (en) |
SI (1) | SI1896401T1 (en) |
WO (1) | WO2006091870A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1740530A2 (en) * | 2004-03-16 | 2007-01-10 | Temple University of the Commonwealth System of Higher Education | Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
WO2011161446A1 (en) | 2010-06-21 | 2011-12-29 | The University Of Nottingham | Compounds for treating proliferative disorders |
US8664272B2 (en) | 2006-08-30 | 2014-03-04 | Temple University—Of the Commonwealth System of Higher Education | Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia |
US9833498B2 (en) | 2008-03-06 | 2017-12-05 | Halozyme, Inc. | Methods of treatment of collagen-mediated diseases and conditions |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9730913B2 (en) * | 2011-10-13 | 2017-08-15 | The Johns Hopkins University | High affinity beta lactamase inhibitors |
CA2885217C (en) * | 2012-09-20 | 2019-10-08 | Temple University - Of The Commonwealth System Of Higher Education | Substituted alkyl diaryl derivatives, methods of preparation and uses |
US10383831B2 (en) | 2015-08-03 | 2019-08-20 | Temple University—Of the Commonwealth System of Higher Education | 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use |
CN109320443B (en) | 2017-08-01 | 2021-02-26 | 财团法人工业技术研究院 | Method for preparing compound and method for preparing polymer containing compound |
CN110981770A (en) * | 2019-12-30 | 2020-04-10 | 武汉九州钰民医药科技有限公司 | Process for preparing Rigoserintib as antineoplastic medicine |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4246263A (en) * | 1979-10-15 | 1981-01-20 | Pfizer Inc. | Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions |
CA2305790C (en) * | 1997-10-03 | 2008-09-23 | Temple University - Of The Commonwealth System Of Higher Education | Styryl sulfone anticancer agents |
US6548553B2 (en) | 1997-10-03 | 2003-04-15 | Temple University-Of The Commonwealth System Of Higher Education | Styryl sulfone anticancer agents |
US6201154B1 (en) | 1999-03-31 | 2001-03-13 | Temple University-Of The Commonwealth Of Higher Education | Z-styryl sulfone anticancer agents |
US6762207B1 (en) | 1999-04-02 | 2004-07-13 | Temple University - Of The Commonwealth System Of Higher Education | (E)-styryl sulfone anticancer agents |
US6767926B1 (en) | 1999-10-12 | 2004-07-27 | Temple University - Of The Commonwealth System Of Higher Education | Method for protecting normal cells from cytotoxicity of chemotherapeutic agents |
US6541475B2 (en) | 2000-04-14 | 2003-04-01 | Temple University - Of The Commonwealth System Of Higher Education | α, β-unsaturated sulfones for treating proliferative disorders |
US6486210B2 (en) * | 2000-04-14 | 2002-11-26 | Temple University—Of the Commonwealth System of Higher Education | Substituted styryl benzylsulfones for treating proliferative disorders |
EP1370253B8 (en) | 2001-02-28 | 2008-11-26 | Temple University of the Commonwealth System of Higher Education | Use of alpha, beta unsaturated aryl sulfones for protecting cells and tissues from ionizing radiation toxicity |
CN1173903C (en) * | 2001-07-13 | 2004-11-03 | 中国科学院上海有机化学研究所 | Efficient ring-opening method for ternary nitrogenous or oxygenous small-ring compound |
-
2006
- 2006-02-24 CA CA2599169A patent/CA2599169C/en active Active
- 2006-02-24 US US11/884,601 patent/US8143453B2/en active Active
- 2006-02-24 PT PT67361030T patent/PT1896401E/en unknown
- 2006-02-24 SI SI200631592T patent/SI1896401T1/en unknown
- 2006-02-24 PL PL06736103T patent/PL1896401T3/en unknown
- 2006-02-24 EP EP06736103.0A patent/EP1896401B1/en active Active
- 2006-02-24 WO PCT/US2006/006698 patent/WO2006091870A2/en active Application Filing
- 2006-02-24 ES ES06736103T patent/ES2417135T3/en active Active
- 2006-02-24 AU AU2006216544A patent/AU2006216544B2/en active Active
- 2006-02-24 DK DK06736103.0T patent/DK1896401T3/en active
-
2007
- 2007-08-20 IL IL185400A patent/IL185400A/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
None |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1740530A2 (en) * | 2004-03-16 | 2007-01-10 | Temple University of the Commonwealth System of Higher Education | Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
EP1740530A4 (en) * | 2004-03-16 | 2008-02-27 | Univ Temple | Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
US8664272B2 (en) | 2006-08-30 | 2014-03-04 | Temple University—Of the Commonwealth System of Higher Education | Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia |
US9833498B2 (en) | 2008-03-06 | 2017-12-05 | Halozyme, Inc. | Methods of treatment of collagen-mediated diseases and conditions |
WO2011161446A1 (en) | 2010-06-21 | 2011-12-29 | The University Of Nottingham | Compounds for treating proliferative disorders |
Also Published As
Publication number | Publication date |
---|---|
US20090124828A1 (en) | 2009-05-14 |
PT1896401E (en) | 2013-07-17 |
WO2006091870A3 (en) | 2007-01-18 |
ES2417135T3 (en) | 2013-08-06 |
EP1896401B1 (en) | 2013-04-10 |
AU2006216544A1 (en) | 2006-08-31 |
EP1896401A4 (en) | 2010-07-14 |
EP1896401A2 (en) | 2008-03-12 |
PL1896401T3 (en) | 2014-03-31 |
CA2599169A1 (en) | 2006-08-31 |
US8143453B2 (en) | 2012-03-27 |
CA2599169C (en) | 2013-10-22 |
AU2006216544B2 (en) | 2012-04-05 |
IL185400A0 (en) | 2008-02-09 |
IL185400A (en) | 2014-07-31 |
DK1896401T3 (en) | 2013-06-17 |
SI1896401T1 (en) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1896401B1 (en) | Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis | |
TWI271397B (en) | Resolution of intermediates in the synthesis of substantially enantiomerically pure bicalutamide | |
HU226771B1 (en) | 2-sulfonyloxy-2-(2-chlorophenyl)-acetic acid methyl ester derivatives, process for their preparation and process for the praparation of clopidogrel using the same | |
KR20020091047A (en) | Methods of asymmetrically synthesizing enantiomers of Casodex, its derivatives and intermediates thereof | |
EP2662355A1 (en) | Process for producing a (fluoroalkylthio) acetonitrile | |
AU2004212887A1 (en) | Sulfonamide derivatives as PPAR modulators | |
WO2001000608A1 (en) | Process for the synthesis of n-(4-cyano-3-trifluoromethylphenyl)-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide | |
US10710061B2 (en) | Ion pair catalysis of tungstate and molybdate | |
CN109776324A (en) | Homoallyltrifluoromethyl compound and preparation method thereof | |
CA2666405A1 (en) | Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide | |
CN102056914B (en) | Process for the preparation of 3,4-dihydro-2H-thien[3,2-E]-1,2-thiazin-4-ol 1, 1-dioxide derivatives and intermediates | |
CN1332944C (en) | Amino acid accelerated CuI catalyzed aryl halide and coupling reaction of alkyl sulfonate | |
WO2016039691A1 (en) | Catalysts for making chiral heterocyclic sulfoxides | |
CN110655480B (en) | Synthetic method of sulfone compound | |
KR100358627B1 (en) | Process For Preparing 3-Arylsulfur Hydroxamic Acids | |
KR101896611B1 (en) | Manufacturing method of compound having sulfonyl group | |
WO2015087352A1 (en) | A process for the synthesis of aryl sulfones | |
WO2022008283A1 (en) | Reagents for the polyfluoroalkylthiolation of organic compounds and method for production thereof | |
KR20000053331A (en) | Process and Intermediates for the Preparation of Oxazoline Derivatives | |
CN116082204B (en) | Beta-sulfinyl alkenyl sulfone compound and preparation method and application thereof | |
CA2668951C (en) | Method for the synthesis of n- [3- [ (2-methoxyphenyl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine | |
KR100302349B1 (en) | A process for preparing cisapride | |
CN114213298A (en) | Method for preparing thiosulfonate compound by directly oxidizing thiophenol | |
Aryal | Studies of the Reaction of Rongalite with Epoxides | |
CN113968802A (en) | Synthesis method of chlorinated trifluoromethyl compound of cycloolefine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 185400 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006216544 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2599169 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 6611/DELNP/2007 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006216544 Country of ref document: AU Date of ref document: 20060224 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006736103 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11884601 Country of ref document: US |